Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
28.55
-3.48 (-10.86%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Apnimed Revenue
Apnimed had revenue of $84.81M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $120.15M. In the year 2025, Apnimed had annual revenue of $38.47M with 380.12% growth.
Revenue (ttm)
$120.15M
Revenue Growth
+380.12%
P/S Ratio
13.17
Revenue / Employee
$1,848,462
Employees
65
Market Cap
1.58B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.47M | 30.46M | 380.12% |
| Dec 31, 2024 | 8.01M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
APMD News
- 17 days ago - Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 20 days ago - Apnimed opens at $22.00, IPO priced at $16.00 - TheFly
- 20 days ago - Apnimed 12M share IPO priced at $16.00 - TheFly
- 24 days ago - Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO - Reuters
- 5 weeks ago - Sleep apnea pill maker Apnimed files for US IPO as biotech market revives - Reuters
- 5 weeks ago - Apnimed IPO Registration Document (S-1) - SEC